Medion Diagnostics Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Medion Diagnostics General Information

Description

Develops fast-reacting antisera and potentiators used for immunological research. The company is engaged in developing diagnostic tests particularly for immunohematological applications.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Bonnstrasse 9
  • 3186 Dudingen
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medion Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medion Diagnostics‘s full profile, request access.

Request a free trial

Medion Diagnostics Patents

Medion Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2352678-T3 Test element and procedure for blood analysis. Active 02-Feb-2004 000000000
CA-2554480-A1 Test element and method for testing blood Granted 02-Feb-2004 000000000
CA-2554480-C Test element and method for testing blood Expired - Fee Related 02-Feb-2004 000000000
AU-2005209072-B2 Test element and method for testing blood Ceased 02-Feb-2004 000000000 0
EP-1713589-A1 Test element and method for testing blood Granted 02-Feb-2004 G01N33/80

Medion Diagnostics Executive Team (1)

Name Title Board Seat Contact Info
Peter Schwind Managing Director
To view Medion Diagnostics’s complete executive team members history, request access »